Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

high-dose

high-dose is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 20
Pipeline programs 39
News articles 0
Drug details — high-dose
Class
—
Route
—
Patents
20
Programs
39
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

high-dose is an FDA-listed pharmaceutical active ingredient.

Key facts

INN high-dose

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Browse pipeline
  1. 8 mg aflibercept (BAY 86-5321) (High Dose) Phase 3 · Regeneron UK · Diabetic Macular Edema
  2. Aflibercept High Dose VEGF Trap-Eye (BAY86-5321) Phase 3 · Regeneron UK · Neovascular Age-Related Macular Degeneration
  3. CX842A2303 Phase 3 · Anaxis Pharma · Erosive esophagitis (EE) due to gastroesophageal reflux dise
  4. EFC14771 Phase 3 · Sanofi-Aventis U.S · Respiratory tract diseases - Wheezing, Asthma
  5. High Dose Colchicine (4.8 mg total dose) Phase 3 · Takeda · Gout
  6. INFQ-324-0476 Phase 3 · Abott Laboratories · Influenza immunisation
  7. Keverprazan Hydrochloride tablets + high dose amoxicillin Phase 3 · First People's Hospital · Helicobacter Pylori Infection Helicobacter Pylori Eradicatio
  8. V712-305/EPOPEX Phase 3 · DBV Technologies · Peanut allergy

Related patents

Browse patents

  1. WO 2025114430

    COMPOSITION À LIBÉRATION MODIFIÉE

    Expires Wed May 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. WO 2025030001

    PROCÉDÉS ET COMPOSITIONS POUR LE MAINTIEN DE LA MOBILITÉ ET/OU DE LA MASSE DES MUSCLES SQUELETTIQUES, ET/OU POUR LA RÉCUPÉRATION DE LA FORCE DES MUSCLES SQUELETTIQUES

    Expires Wed Feb 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. WO 2024206551

    COMPOSITIONS ET PROCÉDÉS DE RÉHYDRATATION D'ALGUES MARINES

    Expires Wed Sep 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. WO 2024064327

    OLIGOSACCHARIDES DE LAIT HUMAIN POUR AMÉLIORER LA FONCTION DE BARRIÈRE HÉMATO-ENCÉPHALIQUE

    Expires Wed Mar 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. CA 3256289

    MÉTHODES PERMETTANT DE FAVORISER LA CROISSANCE DE RATTRAPAGE SAINE

    Expires Wed Jan 27 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. CA 3249631

    PROCÉDÉS ET COMPOSITIONS POUR RALENTIR LE DÉVELOPPEMENT DU DIABÈTE OU RÉDUIRE UN RISQUE DE DIABÈTE

    Expires Wed Oct 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. WO 2023159093

    COMPOSITIONS NUTRITIONNELLES COMPRENANT DES OLIGOSACCHARIDES DE LAIT MATERNEL ET DE L'IMMUNOGLOBULINE BOVINE

    Expires Wed Aug 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. WO 2023158844

    COMPOSITIONS NUTRITIONNELLES EN POUDRE TRAITÉES THERMIQUEMENT ET PROCÉDÉS DE MAINTIEN DE (2S)-HESPÉRIDINE

    Expires Wed Aug 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. WO 2023141408

    BÊTA-HYDROXY BÊTA-MÉTHYLBUTYRATE ET FLAVONOÏDE D'AGRUME POUR FAVORISER LA RÉGÉNÉRATION MUSCULAIRE

    Expires Wed Jul 22 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. WO 2022226311

    COMPOSITIONS NUTRITIONNELLES COMPRENANT DES OLIGOSACCHARIDES DE LAIT HUMAIN ET UN CONSTITUANT LIPIDIQUE DÉSIGNÉ D'AMÉLIORATION DE FONCTION PULMONAIRE

    Expires Wed Oct 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. WO 2022225779

    MÉTHODES ET COMPOSITIONS PERMETTANT DE FAVORISER LA CICATRISATION DE PLAIES

    Expires Wed Oct 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. WO 2022177965

    COMPOSITIONS NUTRITIONNELLES COMPRENANT DES OLIGOSACCHARIDES DU LAIT HUMAIN ET DE L'IMMUNOGLOBULINE BOVINE

    Expires Wed Aug 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. CA 3206564

    PROCEDES ET COMPOSITIONS NUTRITIONNELLES PERMETTANT D'AMELIORER LA PRODUCTION D'ENERGIE MUSCULAIRE ET/OU LA FORCE MUSCULAIRE

    Expires Wed Jul 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. CA 3198544

    PROCEDES D'AUGMENTATION DE LA TAILLE ET DE PROMOTION DE LA CROISSANCE OSSEUSE LINEAIRE

    Expires Thu May 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11207270

    Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances

    Expires Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11197928

    Sustained production of high affinity antigen specific antibody by high dose BAFF receptor-targeting mAb-siRNA conjugate

    Expires Mon Dec 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11090269

    Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances

    Expires Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 10987310

    Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances

    Expires Mon Apr 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 10966931

    Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances

    Expires Mon Apr 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 10959956

    Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances

    Expires Mon Mar 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is high-dose?

high-dose is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.